Silvia Estarriaga‐Navarro, Nieves Goicoechea, Daniel Plano, Carmen Sanmartín
9 min
Selenium (Se) is an essential micronutrient for human, animal, and plant health, yet deficiency is a widespread global concern. Selenium biofortification—the practice of increasing Se content in crops—serves as a multi-functional strategy to combat this deficiency. By modulating metabolic pathways, Se application boosts a plant's ability to resist abiotic and biotic stresses, improves crop yield, and enhances the accumulation of health-promoting compounds such as antioxidants. When consumed, these biofortified crops can contribute to the prevention and management of various diseases, including cancer, inflammatory conditions, and certain allergies.
Plants absorb selenium from the soil in inorganic forms like selenate (SeO42-) and selenite (SeO32-), which are then converted into organic species such as selenocysteine (SeCys) and selenomethionine (SeMet). Researchers have explored various application strategies, including foliar spraying, soil fertilization, and hydroponic systems. Foliar application is generally regarded as highly effective because it avoids soil-related sequestration. Emerging research also highlights the potential of selenium nanoparticles (SeNPs), which can be naturally synthesized within plants, offering a low-toxicity alternative with high bioavailability.
A significant portion of selenium often accumulates in non-edible plant parts, such as husks, stems, and leaves. Rather than viewing these as agricultural waste, the authors propose a circular economy framework where these residues are repurposed for biomedical or nutritional applications. By integrating these selenium-rich byproducts into biorefineries, producers can create high-value products like pharmaceuticals and supplements. Furthermore, the incorporation of artificial intelligence (AI) in these processes allows for real-time monitoring and optimized bioconversion, ensuring that biofortification remains both economically viable and sustainable for the long term.
Despite the clear nutritional advantages, widespread adoption faces hurdles, including the need for global regulatory standardization to prevent selenium toxicity (selenosis), which can occur if dosage levels are not strictly managed. Additionally, consumer and farmer acceptance remains a challenge, often stemming from limited knowledge or food neophobia. Addressing these gaps through clear public communication, supportive agricultural policies, and robust cost-effectiveness evaluations is essential for scaling biofortification to meet future food security goals.
Selenium (Se) biofortification in crops has emerged as a promising strategy to address global Se deficiencies and enhance both agricultural productivity and human health. Increasing the Se content of crops through biofortification improves their resilience to abiotic and biotic stresses and boosts their nutritional value. This benefits human health by protecting against diseases such as cancer, infections and allergies when the crops are consumed. Furthermore, Se-biofortified non-edible plant parts have significant potential in biomedicine and could enhance the value of agricultural byproducts. This strategy contributes to a circular economy by reducing waste, improving resource efficiency and providing sustainable alternatives to synthetic pharmaceuticals and supplements. Ultimately, it supports environmental and economic sustainability. Nevertheless, Se biofortification faces several challenges, particularly with regard to standardization, acceptance by consumers and farmers, and the regulatory and economic frameworks that govern its implementation. Effectively addressing these issues is crucial to unlocking the full potential of Se biofortification. This could significantly improve global nutritional outcomes, reduce the prevalence of Se deficiency-related health conditions, support the prevention and treatment of diseases and promote sustainable agricultural practices that align with long-term food security goals. In this context, future perspectives highlight the promising integration of biofortified residues generated by Se biofortification with emerging technologies such as biorefineries and artificial intelligence. These residues could be efficiently valorized and repurposed through biorefinery processes optimized by artificial intelligence, contributing to a circular economy and sustainable resource management. © 2025 The Author(s). Journal of the Science of Food and Agriculture published by John Wiley & Sons Ltd on behalf of Society of Chemical Industry.
Sam: That makes the dose-response relationship central. What concrete example shows the difference between helping a plant and harming it?
Alex: In a hydroponic study, where plants grew in nutrient solution, purple lettuce benefited at selenium concentrations up to eight micromoles per litre. At sixteen, growth was inhibited. Those are concentrations in the growing solution, not safe intake levels for people.
Sam: So doubling that solution concentration crossed from promoting growth to inhibiting it in that setting. We should not carry the lower concentration straight across to another crop.
Alex: The review supports that caution. Responses depend on crop species, selenium form, application method, and developmental stage. It also describes some lettuce cultivars in which enrichment reduced other essential minerals. Increasing selenium alone is not a complete measure of nutritional quality.
Sam: What explains the beneficial side? The review repeatedly connects selenium with protection against stress, rather than simply faster growth.
Alex: It describes stronger antioxidant defenses, which help limit damage from reactive molecules. In one rice study, an antioxidant enzyme’s activity increased by about 186 percent after selenium was applied to roots. That is a biochemical response in grain, not a measured improvement in human health.
Sam: That distinction matters because the review also discusses cancer, infections, and allergies. How far does the evidence actually travel from enriched plants to disease prevention?
Alex: The examples span different experimental systems. Enriched peanut material inhibited proliferation in cancer cell lines. A diet containing enriched chickpea sprouts reduced tumor growth in immune-suppressed mice carrying implanted human colon cancer cells. Neither result establishes cancer prevention in people eating those foods.
Sam: The mouse diet is closer to eating food than a cell extract is. But it still tests a particular cancer model, not ordinary diets across a human population.
Alex: And that is how I would read it. The review makes broad claims about potential health protection, but these examples provide preclinical support. The excerpt supplies no pooled estimate of clinical benefit, and it does not report sample sizes for the studies we’ve discussed.
Sam: Does the anti-inflammatory evidence have the same limitation? A change in a cell signal can be useful without being a treatment result.
Alex: Yes. An amaranth-sprout extract reduced an inflammatory signal in activated mouse immune cells. Separately, a rat study combined tomato lipid extract with a selenium compound and reported effects on prostate-related inflammation. That combination should not be described as a human trial of selenium-biofortified tomatoes.
Sam: Now to the part that broadens the review. If researchers already study enriched food, what changes when they follow selenium into the leftovers?
Alex: They find that the edible portion is not always the main destination. Studies of wheat and broad beans found greater accumulation in non-edible tissues, including roots, stems, and husks. Material usually discarded or used as animal feed may therefore contain substantial selenium.
Sam: That sounds like both an opportunity and a complication. Enrichment intended for food could leave a valuable fraction outside the harvest people actually eat.
Alex: That is the authors’ circular-economy argument: reducing waste by turning byproducts into useful materials. Residues may also contain antioxidants, vitamins, and phenolic compounds. With careful processing, the authors suggest they could supply bioactive ingredients or other higher-value products.
Sam: But selenium in a husk is not yet a safe supplement. How much evidence is there for actually using these non-edible parts?
Alex: The review says few studies have examined their biomedical or nutritional applications. So residue valorization—creating value from those residues—is a promising direction, not a demonstrated production system. The finding that selenium accumulates there is firmer than the proposed downstream benefits.
Sam: The authors also discuss biorefineries and artificial intelligence. Where do those fit without making the proposal sound more mature than it is?
Alex: A biorefinery converts biological material into useful products. The authors envision processing enriched residues into products ranging from nutritional ingredients to biomaterials and fertilizers. They propose artificial intelligence for tasks such as classifying feedstock quality and adjusting processing conditions. The excerpt does not demonstrate that integrated selenium-residue system.
Sam: Before anyone scales either food enrichment or residue processing, the same constraint returns: controlling exposure. What does the review say about human toxicity?
Alex: It says toxicity symptoms generally appear above approximately 400 micrograms a day. Excess exposure can cause selenosis, an illness involving effects such as hair loss, brittle nails, and gastrointestinal disturbances. Susceptibility also depends on individual factors and exposure from other sources, including supplements and water.
Sam: So implementation needs more than a successful crop experiment. Farmers need a workable method, consumers need confidence, and regulators need consistent products.
Alex: The review identifies all those barriers. Farmers worry about yields, demand, and financial returns. International standardization remains fragmented, especially for agricultural application methods. The authors call for crop-specific optimization, monitoring, clearer rules, and communication that supports informed acceptance.
Sam: Who should read the full review, then, and where should they start if they want to distinguish actionable evidence from the longer-term agenda?
Alex: Crop and nutrition researchers should start with “Challenges of selenium biofortification,” especially safety and standardization. Researchers developing biomass products should read “Selenium accumulation in non-edible parts of biofortified plants,” then the future perspectives. Keep the observed accumulation separate from the proposed products. For everyone else: selenium enrichment is a balancing problem, not a race to the highest concentration.
Sam: Keep the dose in view, alongside the promise.